These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 12530099)
1. PSC 833 modulation of multidrug resistance to paclitaxel in cultured human ovarian carcinoma cells leads to apoptosis. Duraj J; Sedlak J; Bies J; Chovancova J; Chorvath B Anticancer Res; 2002; 22(6A):3425-8. PubMed ID: 12530099 [TBL] [Abstract][Full Text] [Related]
2. PSC 833 induces apoptosis in drug-sensitive human leukemia cell line and modulates resistance to paclitaxel in its multidrug-resistant variant. Duraj J; Takacsova X; Sedlak J; Sulikova M; Hunakova L; Bies J; Chorvath B Anticancer Res; 2000; 20(6B):4627-32. PubMed ID: 11205313 [TBL] [Abstract][Full Text] [Related]
3. Resistance of human multidrug-resistant neoplastic cell lines to paclitaxel-induced-radiosensitization is reduced by the non-immunosuppressive cyclosporine analog SDZ PSC 833. Sedlak J; Hunakova L; Chorvath M; Sulikova M; Novotny L; Boljesikova E; Zeillinger R; Chorvath B Anticancer Res; 1998; 18(4C):3099-105. PubMed ID: 9713517 [TBL] [Abstract][Full Text] [Related]
4. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin. Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878 [TBL] [Abstract][Full Text] [Related]
5. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel. Mitsuuchi Y; Johnson SW; Selvakumaran M; Williams SJ; Hamilton TC; Testa JR Cancer Res; 2000 Oct; 60(19):5390-4. PubMed ID: 11034077 [TBL] [Abstract][Full Text] [Related]
6. Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53. Jones NA; Turner J; McIlwrath AJ; Brown R; Dive C Mol Pharmacol; 1998 May; 53(5):819-26. PubMed ID: 9584207 [TBL] [Abstract][Full Text] [Related]
7. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971 [TBL] [Abstract][Full Text] [Related]
8. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis. Liu JR; Fletcher B; Page C; Hu C; Nunez G; Baker V Gynecol Oncol; 1998 Sep; 70(3):398-403. PubMed ID: 9790794 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis induced by extracellular glutathione is mediated by H(2)O(2) production and DNA damage. Perego P; Gatti L; Carenini N; Dal Bo L; Zunino F Int J Cancer; 2000 Aug; 87(3):343-8. PubMed ID: 10897038 [TBL] [Abstract][Full Text] [Related]
10. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas. Song K; Li Z; Seth P; Cowan KH; Sinha BK Oncol Res; 1997; 9(11-12):603-9. PubMed ID: 9563008 [TBL] [Abstract][Full Text] [Related]
12. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy. Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753 [TBL] [Abstract][Full Text] [Related]
13. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells. Huang Y; Ibrado AM; Reed JC; Bullock G; Ray S; Tang C; Bhalla K Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089 [TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype. Lopes EC; Garcia M; Benavides F; Shen J; Conti CJ; Alvarez E; Hajos SE Leuk Res; 2003 May; 27(5):413-23. PubMed ID: 12620293 [TBL] [Abstract][Full Text] [Related]
15. Lonidamine as a modulator of taxol activity in human ovarian cancer cells: effects on cell cycle and induction of apoptosis. Orlandi L; Zaffaroni N; Bearzatto A; Villa R; De Marco C; Silvestrini R Int J Cancer; 1998 Oct; 78(3):377-84. PubMed ID: 9766575 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone. Sugimura M; Sagae S; Ishioka S; Nishioka Y; Tsukada K; Kudo R Oncology; 2004; 66(1):53-61. PubMed ID: 15031599 [TBL] [Abstract][Full Text] [Related]
17. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line. Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763 [TBL] [Abstract][Full Text] [Related]
18. Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells. Chun E; Lee KY Biochem Biophys Res Commun; 2004 Mar; 315(3):771-9. PubMed ID: 14975768 [TBL] [Abstract][Full Text] [Related]
20. Differences in induction of p53, p21WAF1 and apoptosis in relation to cell cycle phase of MCF-7 cells treated with camptothecin. Deptala A; Li X; Bedner E; Cheng W; Traganos F; Darzynkiewicz Z Int J Oncol; 1999 Nov; 15(5):861-71. PubMed ID: 10536167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]